Atlas Trials

A Study to Assess the Pharmacokinetics of Ceftaroline in End Stage Renal Disease Patients and Matched Healthy Subjects

Clinical trial NCT01664065 · COMPLETED

Trial details

NCT number
NCT01664065
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Disease
Start date
2013-02-01
Primary completion
2013-11-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.